Healthcare Sector Institutional Ownership
Track institutional ownership across the Healthcare sector based on the latest SEC 13F filings for 2026. It aggregates holdings reported by hedge funds, asset managers, and other institutional investors to identify the most widely held Healthcare stocks. The Healthcare sector is currently dominated by top companies, with HUMANA INC (HUM), UNITEDHEALTH GROUP INCORPORATED (UNH), CVS HEALTH CORPORATION (CVS), DAVITA INC (DVA) representing the largest institutional exposures by total reported value. These rankings reflect institutional portfolio allocation trends and provide insight into hedge fund exposure, sector concentration, and long-term institutional conviction in technology equities.
The table below shows the top Healthcare sector holdings ranked by total reported institutional value and number of institutional holders.
| Symbol | Name | Institutions owned | Quantity | Total Value |
|---|---|---|---|---|
| HUM | HUMANA INC | 5 | 19,204,631 | $7,628,463,317 |
| UNH | UNITEDHEALTH GROUP INCORPORATED | 20 | 17,821,066 | $7,406,969,532 |
| CVS | CVS HEALTH CORPORATION | 11 | 69,456,422 | $7,185,212,490 |
| DVA | DAVITA INC | 3 | 28,889,400 | $6,427,313,712 |
| ELV | ELEVANCE HEALTH INC FORMERLY | 13 | 10,100,649 | $3,906,223,709 |
| CI | THE CIGNA GROUP | 8 | 13,551,289 | $3,735,819,234 |
| TMO | THERMO FISHER SCIENTIFIC INCORPORATED | 11 | 7,379,456 | $3,699,764,633 |
| REGN | Regeneron Pharmaceuticals, Inc. | 6 | 5,396,740 | $3,365,083,569 |
| GILD | GILEAD SCIENCES INCORPORATED | 6 | 26,164,267 | $3,305,593,534 |
| DHR | DANAHER CORP DEL | 14 | 16,138,127 | $3,073,990,251 |
| BDX | BECTON DICKINSON & COMPANY | 7 | 19,565,379 | $2,960,830,727 |
| BAX | BAXTER INTL INC | 7 | 138,247,331 | $2,947,433,102 |
| GEHC | GE HealthCare Technologies, Inc. | 7 | 42,101,371 | $2,694,908,764 |
| GSK | GSK PLC ADR | 7 | 48,597,825 | $2,547,497,928 |
| LLY | ELI LILLY & COMPANY | 13 | 1,992,434 | $2,389,785,028 |
| WAT | WATERS CORP | 8 | 6,371,149 | $2,389,435,933 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 7 | 25,833,164 | $2,223,977,093 |
| SYK | STRYKER CORPORATION | 9 | 6,616,673 | $2,083,193,163 |
| INCY | Incyte Corporation | 4 | 16,246,431 | $1,841,695,451 |
| ELAN | ELANCO ANIMAL HEALTH INC | 2 | 67,418,557 | $1,659,170,680 |
| AVTR | Avantor Inc (AVTR) | 5 | 154,176,501 | $1,526,347,364 |
| HLN | HALEON PLC ADR | 5 | 154,345,921 | $1,440,044,110 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 3 | 7,926,955 | $1,335,969,363 |
| HCA | HCA HEALTHCARE INC | 6 | 3,421,389 | $1,333,965,279 |
| BMRN | BioMarin Pharmaceuticals | 5 | 23,003,865 | $1,316,281,157 |
| SNY | SANOFI SA | 4 | 28,952,597 | $1,235,117,802 |
| NVO | NOVO-NORDISK A S ADR | 5 | 25,163,323 | $1,206,329,670 |
| NTRA | NATERA INC | 7 | 4,359,045 | $1,183,262,928 |
| IDXX | IDEXX LABS INC | 8 | 2,130,531 | $1,121,596,565 |
| BMY | BRISTOL-MYERS SQUIBB CO | 9 | 18,276,850 | $1,053,112,074 |
| BIO | BIO RAD LABS INC | 2 | 3,422,970 | $1,005,018,177 |
| UHS | UNIVERSAL HLTH SVCS INC | 3 | 6,531,023 | $971,097,870 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 2 | 1,711,269 | $927,216,882 |
| BBIO | BRIDGEBIO PHARMA INC | 3 | 10,810,067 | $805,133,790 |
| EXEL | EXELIXIS INC | 3 | 13,458,285 | $732,265,287 |
| ADPT | Adaptive Biotechnologies Corp | 4 | 32,489,271 | $696,894,858 |
| SOLV | Solventum Corporation | 4 | 8,748,636 | $674,957,261 |
| MEDP | MEDPACE HOLDINGS INC | 8 | 1,199,624 | $633,588,320 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 2 | 1,959,740 | $589,940,425 |
| TEM | TEMPUS AI INC | 2 | 10,042,634 | $581,769,800 |
| JNJ | JOHNSON & JOHNSON | 16 | 2,263,832 | $574,944,153 |
| ISRG | INTUITIVE SURGICAL INC | 7 | 1,291,135 | $513,458,605 |
| TWST | TWIST BIOSCIENCE CORP | 3 | 4,725,114 | $486,119,752 |
| TECH | BIO-TECHNE CORP | 4 | 6,555,272 | $463,129,968 |
| CORT | CORCEPT THERAPEUTICS INC | 2 | 5,269,051 | $458,143,985 |
| TXG | 10X GENOMICS INC | 3 | 11,208,196 | $429,722,398 |
| FMS | FRESENIUS MEDICAL CARE AG | 3 | 18,858,518 | $426,391,095 |
| ALGN | ALIGN TECHNOLOGY INC | 6 | 2,598,122 | $411,712,939 |
| ABT | Abbott Labs | 12 | 4,270,164 | $387,474,807 |
| NVST | ENVISTA HOLDINGS CORPORATION | 6 | 14,315,198 | $377,205,469 |
| BEAM | BEAM THERAPEUTICS INC | 3 | 10,833,462 | $371,804,847 |
| ZTS | Zoetis Inc Class A | 7 | 5,159,444 | $370,757,631 |
| PFE | PFIZER INCORPORATED | 13 | 15,098,789 | $363,557,905 |
| BNTX | BioNTech SE | 2 | 3,810,924 | $354,606,465 |
| VEEV | VEEVA SYSTEMS INCORPORATED CLASS A COM | 11 | 1,928,239 | $351,040,101 |
| MCK | MCKESSON CORPORATION | 5 | 463,356 | $350,110,871 |
| CRL | CHARLES RIV LABS INTL INC | 2 | 1,508,990 | $342,223,812 |
| ALKS | ALKERMES PLC | 2 | 6,469,165 | $338,951,903 |
| ILMN | ILLUMINA INC | 3 | 1,879,237 | $330,426,206 |
| PRVA | PRIVIA HEALTH GROUP INC | 2 | 12,268,648 | $315,672,313 |
| ROIV | ROIVANT SCIENCES LTD | 5 | 8,812,175 | $311,862,874 |
| NTLA | INTELLIA THERAPEUTICS INC | 2 | 18,275,688 | $309,224,643 |
| NVS | NOVARTIS AG SPONSORED ADR | 8 | 1,729,739 | $271,085,103 |
| TFX | TELEFLEX INCORPORATED | 3 | 2,087,906 | $264,663,125 |
| TEVA | Teva Pharmaceutical Industries Ltd. - ADR | 6 | 7,843,618 | $259,448,871 |
| MRK | Merck Inc | 12 | 1,995,390 | $256,396,624 |
| CNC | CENTENE CORP DEL | 4 | 3,906,260 | $250,742,843 |
| IONS | IONIS PHARMACEUTICALS INC. | 4 | 3,144,062 | $249,292,687 |
| MOH | MOLINA HEALTHCARE INC | 4 | 1,078,436 | $241,970,321 |
| BTSG | BRIGHTSPRING HEALTH SVCS INC | 4 | 3,359,721 | $234,306,943 |
| PBH | PRESTIGE CONSMR HEALTHCARE I | 2 | 4,876,658 | $230,519,625 |
| WRBY | Warby Parker Inc Cl A | 4 | 6,973,849 | $211,586,578 |
| IQV | IQVIA HLDGS INCORPORATED | 4 | 1,057,506 | $204,331,344 |
| VRTX | VERTEX PHARMACEUTICALS INC | 4 | 392,073 | $194,754,559 |
| BSX | BOSTON SCIENTIFIC CORP | 7 | 4,458,647 | $190,295,060 |
| WST | WEST PHARMACEUTICAL SVSC INC | 4 | 485,617 | $174,336,572 |
| HAE | HAEMONETICS CORP MASS | 3 | 2,195,024 | $164,626,800 |
| INSM | INSMED INC | 2 | 1,428,155 | $152,269,439 |
| RXRX | Recursion Pharmaceuticals Inc | 2 | 41,348,835 | $151,750,227 |
| ABSI | Absci Corp | 1 | 12,925,271 | $149,803,896 |
| SDGR | SCHRODINGER INC | 2 | 9,135,682 | $148,454,837 |
| BKD | BROOKDALE SR LIVING INC | 4 | 9,199,719 | $148,023,478 |
| LH | Labcorp, Inc | 4 | 501,369 | $140,383,386 |
| CAH | CARDINAL HEALTH INC | 5 | 578,814 | $137,502,944 |
| VCYT | Veracyte Inc | 1 | 2,295,951 | $134,841,222 |
| HSIC | SCHEIN HENRY INC | 4 | 1,603,743 | $133,944,633 |
| AMGN | AMGEN INCORPORATED | 6 | 361,083 | $130,755,219 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 2 | 4,412,186 | $130,291,852 |
| OPCH | OPTION CARE HEALTH INC | 1 | 6,163,722 | $129,253,250 |
| HNGE | HINGE HEALTH INC | 3 | 1,461,542 | $121,307,986 |
| ENSG | ENSIGN GROUP INC | 4 | 754,902 | $121,010,793 |
| XRAY | DENTSPLY SIRONA INC | 6 | 11,361,341 | $120,543,828 |
| BLCO | BAUSCH PLUS LOMB CORP | 3 | 7,026,042 | $116,351,255 |
| INBX | INHIBRX BIOSCIENCES INC | 2 | 1,186,130 | $112,385,818 |
| EW | EDWARDS LIFESCIENCES CORP | 5 | 1,237,984 | $111,988,009 |
| DXCM | DEXCOM INC | 2 | 1,649,912 | $111,121,599 |
| PSNL | Personalis Inc | 1 | 8,271,339 | $110,835,941 |
| WGS | GeneDx Holdings Corp | 1 | 1,610,189 | $110,539,494 |
| RDY | DR REDDYS LABS LTD | 2 | 7,509,110 | $108,807,011 |
| CDNA | CAREDX INC | 3 | 3,794,987 | $108,157,119 |
| TVTX | TRAVERE THERAPEUTICS INC | 2 | 1,867,394 | $106,086,653 |
| A | Agilent Technologies, Inc. (A) | 4 | 792,513 | $105,269,460 |
| THC | TENET HEALTHCARE CORP | 3 | 1,327,415 | $101,588,983 |
| GMAB | GENMAB A/S | 2 | 3,543,449 | $97,338,535 |
| OSCR | OSCAR HEALTH INC | 2 | 3,323,201 | $94,777,693 |
| RVMD | REVOLUTION MEDICINES INC | 3 | 502,917 | $94,186,643 |
| VTRS | VIATRIS INC | 4 | 6,956,194 | $93,517,729 |
| INVA | INNOVIVA INC | 2 | 4,046,290 | $91,891,247 |
| BAYRY | Bayer AG Spons ADR | 1 | 6,518,603 | $89,307,717 |
| PNTG | PENNANT GROUP INC | 3 | 2,333,153 | $86,210,003 |
| PHG | KONINKLIJKE PHILIPS NV | 3 | 3,133,261 | $85,193,363 |
| BIIB | BIOGEN INC | 4 | 389,408 | $84,135,468 |
| GH | GUARDANT HEALTH INC | 3 | 542,227 | $81,350,359 |
| SHC | SOTERA HEALTH CO | 2 | 4,472,485 | $79,083,336 |
| ABBV | ABBVIE INCORPORATED | 10 | 313,109 | $78,790,827 |
| RMD | RESMED INC | 3 | 394,390 | $76,858,739 |
| SUPN | Supernus Pharmaceuticals Inc | 2 | 1,630,904 | $75,853,345 |
| CPRX | CATALYST PHARMACEUTICALS INC | 2 | 2,346,238 | $73,742,260 |
| DOCS | DOXIMITY INC | 2 | 3,506,973 | $72,734,620 |
| GRAL | GRAIL INC | 2 | 1,043,497 | $71,239,540 |
Frequently asked questions
- What is Healthcare sector institutional ownership?
- It is the set of U.S.-listed equities classified as Healthcare in our reference data, ranked by aggregate reported dollar value held across the institutional managers we track using their latest SEC Form 13F positions. Larger totals generally reflect broader or larger positions among those filers, not the entire market.
- How often is Healthcare sector ownership data updated?
- Rankings reflect each tracked manager’s latest 13F filing on record in 2026. When managers file updates, totals and ordering can change; quarter-end filing waves are the most common time for large shifts.
- How should I use this Healthcare stock list?
- Use it as a starting point to see which Healthcare names are most represented by dollar value among superinvestors we track, then open individual stock pages for holder-level detail, position sizes, and activity. This is not investment advice.